| Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder (NCT04982796) | Portland VA Research Foundation, Inc | 2022-07-07 |
| Implementation and Effectiveness of Multidiscipline-Integrated Addiction Treatment Model (NCT04203654) | National Health Research Institutes, Taiwan | 2020-02-24 |
| Computerized Exercise to Alter Stimulant Approach Responses (NCT03902405) | University of British Columbia | 2018-06-11 |
| Conflict Between Maternal Autonomy and Child Health in Substance-use (NCT02797990) | London School of Hygiene and Tropical Medicine | 2016-05-01 |
| Mephedrone and Alcohol Interactions in Humans (NCT02294266) | Parc de Salut Mar | 2014-12-01 |
| Abuse Liability and Human Pharmacology of Mephedrone (NCT02232789) | Parc de Salut Mar | 2014-09-01 |
| A Cognitive Behavioral Therapy-Based Text Message Intervention for Methamphetamine Dependence (NCT01899313) | California Pacific Medical Center Research Institute | 2014-05-01 |
| Extended-Release Naltrexone to Treat Methamphetamine Dependence in Men Who Have Sex With Men (MSM) (NCT01449565) | San Francisco Department of Public Health | 2012-09-01 |
| Pharmacological Interaction Between Doxazosin and Methylenedioxymethamphetamine (MDMA) (NCT01386177) | University Hospital, Basel, Switzerland | 2011-07-01 |
| Pharmacological Interaction Between Carvedilol and Methylenedioxymethamphetamine (MDMA) (NCT01270672) | University Hospital, Basel, Switzerland | 2011-01-01 |
| Pharmacological Interaction Between Clonidine and Methylenedioxymethamphetamine (MDMA) (NCT01136278) | University Hospital, Basel, Switzerland | 2010-07-01 |
| Interaction Between Duloxetine and 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) (NCT00990067) | University Hospital, Basel, Switzerland | 2009-11-01 |
| Interaction Between Reboxetine and 3,4-Methylenedioxymethamphetamine: Pharmacodynamics (PD) and Pharmacokinetics (PK) (NCT00886886) | University Hospital, Basel, Switzerland | 2009-04-01 |
| Contingency Management for Methamphetamine Abstinence and HIV Post-Exposure Prophylaxis in Men Who Have Sex With Men (NCT00856323) | Friends Research Institute, Inc. | 2009-01-01 |
| Investigation of Serotonin Neurotransmission in MDMA Users Using Combinated Dexfenfluramine Challenge and PET Imaging (NCT01296802) | University of Zurich | 2006-04-01 |
| Functional Brain Imaging in Recreational Users of Ecstasy (NCT00254306) | Hadassah Medical Organization | 2006-01-01 |
| Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant Abuse (NCT00248092) | New River Pharmaceuticals | 2006-01-01 |
| Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories (NCT00247572) | New River Pharmaceuticals | 2005-09-01 |
| Assessment of Interactions Between Intravenous Methamphetamine and Modafinil - 1 (NCT00265278) | National Institute on Drug Abuse (NIDA) | 2005-03-01 |
| To Assess the Safety and Tolerability of 7.5, 15 and 30 mg of Sublingual Lobeline. - 1 (NCT00100074) | National Institute on Drug Abuse (NIDA) | 2004-09-01 |
| Assessment of Interactions Between Methamphetamine and Aripiprazole - 1 (NCT00089440) | National Institute on Drug Abuse (NIDA) | 2004-06-01 |
| A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1 (NCT00267657) | National Institute on Drug Abuse (NIDA) | 2004-01-01 |
| Bupropion for the Treatment of Methamphetamine Dependence - 1 (NCT00069251) | National Institute on Drug Abuse (NIDA) | 2003-07-01 |
| Ondansetron for the Treatment of Methamphetamine Dependence - 1 (NCT00040053) | National Institute on Drug Abuse (NIDA) | 2002-06-01 |
| Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1 (NCT00040040) | National Institute on Drug Abuse (NIDA) | 2002-06-01 |
| Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1 (NCT00033072) | National Institute on Drug Abuse (NIDA) | 2001-09-01 |
| Pharmacological Interaction Between Pindolol and MDMA (3,4-Methylenedioxymethamphetamine) (NCT00895804) | University Hospital, Basel, Switzerland | 2001-06-01 |
| Effects of Stimulant Dependence on Human Striatal Dopamine System - 15 (NCT00000350) | National Institute on Drug Abuse (NIDA) | 1999-03-01 |
| Tyrosine for Methamphetamine Dependence - 1 (NCT00000322) | National Institute on Drug Abuse (NIDA) | 1997-04-01 |
| Cognitive Correlates of Substance Abuse, Part 2 - 16 (NCT00000351) | National Institute on Drug Abuse (NIDA) | |
| Cognitive Correlates of Substance Abuse - 11 (NCT00000346) | National Institute on Drug Abuse (NIDA) | |